CD84 is markedly up-regulated in Kawasaki disease arteriopathy

R Reindel1, J Bischof, K-Y A Kim

  • 1Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, USA.

Insights

Kawasaki disease (KD) causes persistent inflammation in coronary arteries (CA). Researchers found the CD84 molecule significantly increased in KD CA, indicating potential new therapeutic targets for this childhood illness.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Molecular Biology

Background:

  • Kawasaki disease (KD) is a critical pediatric illness affecting coronary arteries (CA).
  • Current KD therapies aim to reduce inflammation and prevent thrombosis but are not universally effective.
  • The unknown molecular pathogenesis of KD hinders the development of novel treatments.

Purpose of the Study:

  • To identify dysregulated gene expression in KD CA.
  • To investigate the role of specific molecules in KD pathogenesis.
  • To provide molecular evidence for persistent inflammation in KD-affected CA.

Main Methods:

  • High-throughput RNA sequencing of KD and control CA.
  • Validation of gene expression using real-time reverse transcription-polymerase chain reaction (RT-PCR).
  • Immunohistochemistry to localize protein expression in tissues.

Main Results:

  • Signalling lymphocyte activation molecule CD84 was significantly upregulated in both acute (16-fold) and chronic (32-fold) KD CA.
  • CD84 was localized to inflammatory cells within KD tissues.
  • Genes related to cellular proliferation, motility, survival, and immune activation (MX2, SP140) were also upregulated in KD CA.

Conclusions:

  • CD84 is markedly upregulated in KD CA, playing a role in immune responses and platelet stabilization.
  • This study provides the first molecular evidence of sustained dysregulated inflammatory responses in CA damaged by KD.
  • Findings suggest CD84 as a potential therapeutic target for Kawasaki disease.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.6K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K